IVDR vs IVDD Classification: Key Regulatory Changes Every IVD Manufacturer Should Understand

Wiki Article



How to Classify an In Vitro Diagnostic Device Under EU IVDR: A Practical Step-by-Step Guide


Determining the correct classification of an in vitro diagnostic device is one of the first regulatory activities manufacturers should complete when preparing for the European market. A product's classification influences its conformity assessment route, notified body requirements, technical documentation, and performance evaluation obligations.


However, classification is not always straightforward. A diagnostic product may have several intended purposes, multiple analytes, different user groups, or applications involving different medical conditions. Manufacturers must understand how these characteristics relate to the seven rules in Annex VIII of Regulation (EU) 2017/746.


A structured classification process can help prevent unnecessary regulatory uncertainty. I3CGlobal provides IVDR classification information and regulatory consulting resources that explain the four classes, classification rules, and CE marking considerations.



Step 1: Define the Intended Purpose of Your IVD Device


The first step is to establish exactly what the product is intended to do. The intended purpose describes the medical application for which the manufacturer designs the device. It may involve detecting a particular substance, identifying an infectious agent, measuring a biological marker, or providing information relevant to diagnosis or treatment decisions.


Manufacturers should avoid using vague descriptions that do not explain the actual diagnostic application. A clear intended purpose helps identify the relevant Annex VIII classification rule and supports the preparation of technical documentation.



Identify the Diagnostic Application


Consider whether the device is intended for screening, diagnosis, monitoring, prognosis, disease staging, or treatment selection. Also identify the target condition, analyte, specimen type, and clinical context.


For example, a test intended for general laboratory measurement may be assessed differently from an assay designed to detect a serious infectious disease. The specific intended purpose determines which classification provisions require evaluation.



Step 2: Identify the Intended User and Testing Environment


The intended user is another important classification consideration. An IVD device may be designed for use by trained laboratory professionals, healthcare professionals in near-patient settings, or individuals performing self-tests at home.


Rule 4 specifically addresses self-testing devices. Most self-testing devices are Class C, although certain specified categories are Class B. Near-patient testing devices are classified according to the other applicable rules rather than automatically receiving a particular class.


Manufacturers should ensure that product labelling, instructions for use, and promotional claims accurately describe the intended testing environment and user.



Step 3: Work Through the Seven Annex VIII Classification Rules


After defining the intended purpose and intended user, manufacturers should systematically review all seven classification rules. It is important to consider every relevant rule rather than stopping at the first one that appears applicable.



The manufacturer should record which rules were considered, whether each rule applies, and the reasoning supporting the final classification.



Step 4: Determine the Highest Applicable Risk Class


A device may have more than one intended purpose or may fall under several classification rules. In such situations, the manufacturer must apply the rule resulting in the highest class.


For example, an IVD product with several diagnostic claims should not be classified only according to its lowest-risk application. Every intended use must be evaluated, and the classification rationale should explain how the different rules were considered.



Reviewing Multiple Analytes and Claims


Manufacturers developing multi-analyte assays should examine whether each analyte serves the same intended purpose or supports different medical applications. Different claims may create different regulatory considerations.


Similarly, a test intended for both professional laboratory use and home self-testing requires careful evaluation of the self-testing provisions. The final classification must reflect the relevant intended purposes and applicable rules.



Step 5: Evaluate Software, Accessories, and Calibrators


Classification does not apply only to conventional laboratory assays. The IVDR also contains implementing provisions covering software, accessories, and other products used alongside IVD devices.



IVD Software Classification


Software that drives or influences an IVD device takes the classification of the device it drives or influences. Standalone IVD software is classified in its own right using the Annex VIII rules.


Manufacturers should clearly define the software's intended purpose and explain how its output contributes to an IVD procedure. The software's regulatory role should be reflected consistently in the product documentation.



Accessories and Calibrators


Accessories are classified separately according to their own intended purpose. This means an accessory should not automatically receive the same classification as the primary diagnostic device.


Calibrators follow the classification of the device they are intended to calibrate. Controls without assigned values are addressed separately under Rule 7 and generally fall into Class B.



Step 6: Prepare a Written Classification Rationale


Once the relevant rules have been evaluated, the manufacturer should prepare a written classification rationale. This document provides the reasoning behind the final risk category and creates traceability for future regulatory reviews.


A useful classification rationale should identify the device, its intended purpose, applicable Annex VIII rules, relevant implementing provisions, and the final classification decision.


It should also explain why potentially relevant higher-risk rules do or do not apply. This is especially important for products with multiple intended purposes or complex diagnostic claims.



Information to Include in the Classification File




Step 7: Identify the Applicable Conformity Assessment Route


After determining the class, manufacturers should identify the relevant conformity assessment procedure. Class A devices generally follow manufacturer self-declaration, except for applicable sterile aspects. Class B, C, and D devices require notified body involvement.


The conformity assessment options are set out in the IVDR. They include procedures involving quality management system assessment, technical documentation assessment, EU type examination, and production quality assurance, depending on the device class and applicable provisions.


Class D devices have additional requirements involving applicable EU reference laboratory performance verification and batch verification. Certain novel Class D devices also involve expert panel consultation.



Step 8: Connect Classification With Technical Documentation


The classification decision should be consistent with the technical documentation. The product description, intended purpose, risk management information, performance evaluation, labelling, and instructions for use should support the same regulatory position.


For higher-risk products, manufacturers should pay particular attention to analytical performance, clinical performance, scientific validity, and the evidence supporting the diagnostic claims.


Classification should also be reconsidered when a manufacturer changes the intended purpose, adds new claims, modifies the intended user, or expands the product into additional diagnostic applications.



Common Issues During the Classification Process


Manufacturers sometimes focus too heavily on the technology used in a diagnostic product. However, technology alone does not determine the risk class. The intended purpose and consequences of an incorrect result remain central to the Annex VIII assessment.


Another common issue is overlooking exceptions within the classification rules. For example, most self-tests are Class C, but certain specified self-testing applications are Class B. Similarly, blood grouping devices can fall into different classes depending on the specific system involved.



How I3CGlobal Can Assist With IVDR Classification


I3CGlobal offers regulatory consulting information and services covering IVDR classification, IVDR CE marking, technical documentation, and related regulatory activities. Its classification guide explains the seven rules, the four risk classes, and the conformity assessment implications of different device categories.


Manufacturers can use these resources to understand the regulatory process and identify areas that require additional assessment. A detailed classification review can be particularly useful when dealing with multiple intended purposes, software, or higher-risk diagnostic applications.



Conclusion


Classifying an IVD device under EU IVDR requires a systematic evaluation of its intended purpose, target application, intended users, and potential risks. Reviewing all seven Annex VIII rules and applying the highest applicable classification are essential steps in reaching a defensible decision.

A documented classification rationale should IVDR Classification then guide the conformity assessment strategy and technical documentation process. Using regulatory resources from IVDR Classification I3CGlobal and carefully reviewing the applicable legal requirements can help manufacturers establish a structured approach to IVDR CE marking.

Report this wiki page